What is the current annual EBITDA of EXEL?

As of today, EXEL annual EBITDA is $921.76M

What is 1-year change in EXEL annual EBITDA?

EXEL annual EBITDA is up +28.24% year-over-year

What is 3-year change in EXEL annual EBITDA?

EXEL annual EBITDA is up +314.54% over the past 3 years

How far is EXEL annual EBITDA from its all-time high?

EXEL annual EBITDA is currently at its all-time high

How does EXEL annual EBITDA rank versus sector peers?

EXEL annual EBITDA is higher than 92.74% of companies in Healthcare sector

When is EXEL next annual earnings release?

The next annual earnings release for EXEL is on February 9, 2027

What is the current quarterly EBITDA of EXEL?

As of today, EXEL quarterly EBITDA is $275.36M

What is EXEL quarterly EBITDA most recent change?

EXEL quarterly EBITDA was up +7.82% on September 1, 2026

What is 1-year change in EXEL quarterly EBITDA?

EXEL quarterly EBITDA is up +4.39% year-over-year

How far is EXEL quarterly EBITDA from its all-time high?

EXEL quarterly EBITDA is currently -2.93% below its historical high of $283.68M set on June 28, 2024

How does EXEL quarterly EBITDA rank versus sector peers?

EXEL quarterly EBITDA is higher than 92.51% of companies in Healthcare sector

When is EXEL next earnings release?

The next earnings release for EXEL is on February 9, 2027

What is the current TTM EBITDA of EXEL?

As of today, EXEL TTM EBITDA is $1.03B

What is EXEL TTM EBITDA most recent change?

EXEL TTM EBITDA was up +1.13% on September 1, 2026

What is 1-year change in EXEL TTM EBITDA?

EXEL TTM EBITDA is up +21.40% year-over-year

How far is EXEL TTM EBITDA from its all-time high?

EXEL TTM EBITDA is currently at its all-time high

How does EXEL TTM EBITDA rank versus sector peers?

EXEL TTM EBITDA is higher than 92.80% of companies in Healthcare sector

When is EXEL next earnings release?

The next earnings release for EXEL is on February 9, 2027

Exelixis, Inc. (EXEL) EBITDA History & Chart Since 1997

Annual EBITDA

$921.76M$203.00M+28.24%

December 1, 2025

Summary

Current Value: As of today, EXEL annual EBITDA is $921.76M, up +28.24% on December 1, 2025
Historical Performance: EXEL annual EBITDA is up +314.54% over the past 3 years, up +643.17% over the past 5 years
All-Time High Comparison: EXEL annual EBITDA is currently at its all-time high
3-Year Low Comparison: EXEL annual EBITDA is +368.84% above its 3-year low of $196.60M reached on December 31, 2023
Sector Comparison: EXEL annual EBITDA is higher than 92.74% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

EXEL Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 1, 25	$921.76M	+28.2%	+314.5%	+643.2%	+2015.9%
Quarterly EBITDA	Sep 1, 26	$275.36M	+4.4%	+2539.6%	+376.5%	+228.8%
TTM EBITDA	Sep 1, 26	$1.03B	+21.4%	+1187.7%	+383.1%	+2231.2%
Price	Nov 5, 26	$68.71	+70.2%	+227.2%	+254.9%	+1512.9%
PE Ratio	Nov 5, 26	20.56	+20.9%	-72.5%	-45.8%	-85.5%
Annual Revenue	Dec 1, 25	$2.32B	+7.0%	+44.0%	+134.9%	+1153.8%
Annual EPS	Dec 1, 25	$2.78	+57.7%	+394.4%	+689.9%	+426.6%
	Dec 1, 25	$892.70M	+29.4%	+343.1%	+711.1%	+1622.0%
Annual Net Income	Dec 1, 25	$782.57M	+50.1%	+329.3%	+600.1%	+947.6%

EBITDA Highs

EXEL Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$921.76M	Dec 1, 25	at high
5Y	$921.76M	Dec 1, 25	at high
All	$921.76M	Dec 1, 25	at high

EBITDA Lows

EXEL Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$196.60M	Dec 31, 23	+368.8%
5Y	$124.03M	N/A	+643.2%
All	-$214.97M	Dec 31, 14	+528.8%

EBITDA History

Year	Value	Change
2025	$921.76M	+28.2%
2024	$718.75M	+265.6%
2023	$196.60M	-11.6%
2022	$222.36M	-26.0%
2021	$300.30M	+142.1%
2020	$124.03M	-67.4%
2019	$380.64M	-14.8%
2018	$446.62M	+161.5%
2017	$170.81M	+591.1%
2016	-$34.78M	+66.0%
2015	-$102.17M	+52.5%
2014	-$214.97M	-9.5%
2013	-$196.35M	-82.6%
2012	-$107.55M	-201.0%
2011	$106.49M	+321.4%

Year	Value	Change
2010	-$48.11M	+56.0%
2009	-$109.31M	+33.0%
2008	-$163.20M	-12.0%
2007	-$145.72M	-32.7%
2006	-$109.84M	-44.1%
2005	-$76.24M	+14.4%
2004	-$89.06M	-14.8%
2003	-$77.59M	-10.2%
2002	-$70.41M	-38.8%
2001	-$50.74M	-33.4%
2000	-$38.03M	-129.1%
1999	-$16.60M	-20.6%
1998	-$13.77M	-22.5%
1997	-$11.24M	-

FAQ

What is the current annual EBITDA of EXEL?: As of today, EXEL annual EBITDA is $921.76M
What is 1-year change in EXEL annual EBITDA?: EXEL annual EBITDA is up +28.24% year-over-year
What is 3-year change in EXEL annual EBITDA?: EXEL annual EBITDA is up +314.54% over the past 3 years
How far is EXEL annual EBITDA from its all-time high?: EXEL annual EBITDA is currently at its all-time high
How does EXEL annual EBITDA rank versus sector peers?: EXEL annual EBITDA is higher than 92.74% of companies in Healthcare sector
When is EXEL next annual earnings release?: The next annual earnings release for EXEL is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$275.36M$19.96M+7.82%

September 1, 2026

Summary

Current Value: As of today, EXEL quarterly EBITDA is $275.36M, up +7.82% on September 1, 2026
Historical Performance: EXEL quarterly EBITDA is up +4.39% year-over-year, up +2539.60% over the past 3 years
All-Time High Comparison: EXEL quarterly EBITDA is currently -2.93% below its historical high of $283.68M set on June 28, 2024
3-Year Low Comparison: EXEL quarterly EBITDA is +2539.60% above its 3-year low of -$11.29M reached on an earlier date
Sector Comparison: EXEL quarterly EBITDA is higher than 92.51% of companies in Healthcare sector

Performance

EXEL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 1, 26	$275.36M	+7.8%	+4.4%	+2539.6%	+376.5%
Annual EBITDA	Dec 1, 25	$921.76M	–	+28.2%	+314.5%	+643.2%
TTM EBITDA	Sep 1, 26	$1.03B	+1.1%	+21.4%	+1187.7%	+383.1%
Price	Nov 5, 26	$68.71	+21.2%	+70.2%	+227.2%	+254.9%
PE Ratio	Nov 5, 26	20.56	+15.4%	+20.9%	-72.5%	-45.8%
Quarterly Revenue	Sep 1, 26	$658.70M	+4.8%	+10.2%	+39.6%	+100.6%
Quarterly EPS	Sep 1, 26	$0.85	+4.4%	+22.7%	+10000.0%	+619.1%
	Sep 1, 26	$268.42M	+8.1%	+4.7%	+1626.6%	+420.0%
Quarterly Net Income	Sep 1, 26	$218.10M	+2.9%	+12.7%	+10000.0%	+470.9%

Quarterly EBITDA Highs

EXEL Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$275.36M	Sep 1, 26	at high
3Y	$283.68M	Jun 28, 24	-2.9%
5Y	$283.68M	Jun 28, 24	-2.9%
All	$283.68M	Jun 28, 24	-2.9%

Quarterly EBITDA Lows

EXEL Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$242.86M	Dec 1, 25	+13.4%
3Y	-$11.29M	N/A	+2539.6%
5Y	-$42.13M	Dec 30, 22	+753.6%
All	-$64.44M	Mar 31, 14	+527.3%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$275.36M	+7.8%
Jun 2026	$255.40M	-1.1%
Mar 2026	$258.29M	+6.4%
Dec 2025	$242.86M	-7.9%
Sep 2025	$263.78M	+19.4%
Jun 2025	$220.92M	+13.8%
Mar 2025	$194.20M	+13.5%
Dec 2024	$171.10M	-12.4%
Sep 2024	$195.30M	-31.2%
Jun 2024	$283.68M	+313.1%
Mar 2024	$68.68M	-22.2%
Dec 2023	$88.31M	+882.4%
Sep 2023	-$11.29M	-112.4%
Jun 2023	$91.14M	+114.9%
Mar 2023	$42.42M	+200.7%
Dec 2022	-$42.13M	-144.9%
Sep 2022	$93.76M	+0.2%
Jun 2022	$93.54M	+5.0%
Mar 2022	$89.12M	-24.8%
Dec 2021	$118.58M	+105.2%
Sep 2021	$57.79M	-54.9%
Jun 2021	$128.04M	>+9,900.0%
Mar 2021	-$159.00K	-100.6%
Dec 2020	$27.93M	+171.6%
Sep 2020	-$39.00M	-149.4%
Jun 2020	$78.94M	+40.6%
Mar 2020	$56.16M	-29.4%
Dec 2019	$79.58M	-32.4%
Sep 2019	$117.70M	+25.2%
Jun 2019	$94.03M	+8.7%
Mar 2019	$86.52M	-23.9%
Dec 2018	$113.64M	-10.4%
Sep 2018	$126.88M	+46.6%
Jun 2018	$86.58M	-24.9%
Mar 2018	$115.33M	+206.6%
Dec 2017	$37.62M	-54.4%
Sep 2017	$82.45M	+193.2%
Jun 2017	$28.12M	+33.2%
Mar 2017	$21.11M	-51.0%
Dec 2016	$43.07M	+321.6%
Sep 2016	$10.22M	+153.1%
Jun 2016	-$19.26M	+53.6%
Mar 2016	-$41.52M	-32.4%
Dec 2015	-$31.36M	+10.7%
Sep 2015	-$35.12M	-18.6%
Jun 2015	-$29.60M	-29.3%
Mar 2015	-$22.89M	+47.2%
Dec 2014	-$43.37M	+5.5%
Sep 2014	-$45.90M	+24.5%
Jun 2014	-$60.76M	+5.7%
Mar 2014	-$64.44M	-10.4%
Dec 2013	-$58.38M	-6.1%
Sep 2013	-$55.02M	-10.3%
Jun 2013	-$49.90M	-51.0%

Month	Value	Change
Mar 2013	-$33.05M	-0.6%
Dec 2012	-$32.86M	-41.2%
Sep 2012	-$23.28M	+26.2%
Jun 2012	-$31.56M	-48.4%
Mar 2012	-$21.26M	-137.1%
Dec 2011	$57.31M	-31.6%
Sep 2011	$83.74M	+577.9%
Jun 2011	-$17.52M	-2.9%
Mar 2011	-$17.03M	-246.1%
Dec 2010	-$4.92M	-405.9%
Sep 2010	$1.61M	+112.0%
Jun 2010	-$13.41M	+52.6%
Mar 2010	-$28.32M	-3.8%
Dec 2009	-$27.27M	-160.4%
Sep 2009	-$10.47M	+68.5%
Jun 2009	-$33.22M	-4.8%
Mar 2009	-$31.69M	+4.0%
Dec 2008	-$33.01M	+20.2%
Sep 2008	-$41.34M	+8.9%
Jun 2008	-$45.39M	-4.4%
Mar 2008	-$43.46M	-9.7%
Dec 2007	-$39.61M	+0.3%
Sep 2007	-$39.73M	-10.8%
Jun 2007	-$35.85M	-17.4%
Mar 2007	-$30.53M	-1.3%
Dec 2006	-$30.13M	-9.7%
Sep 2006	-$27.46M	-6.5%
Jun 2006	-$25.78M	+2.6%
Mar 2006	-$26.47M	-9.0%
Dec 2005	-$24.30M	-0.7%
Sep 2005	-$24.14M	-356.1%
Jun 2005	-$5.29M	+76.5%
Mar 2005	-$22.51M	-8.9%
Dec 2004	-$20.66M	+8.2%
Sep 2004	-$22.50M	-0.2%
Jun 2004	-$22.46M	+4.1%
Mar 2004	-$23.43M	-29.2%
Dec 2003	-$18.13M	+10.9%
Sep 2003	-$20.34M	-1.1%
Jun 2003	-$20.11M	-4.9%
Mar 2003	-$19.18M	-28.6%
Dec 2002	-$14.91M	+5.7%
Sep 2002	-$15.81M	+24.1%
Jun 2002	-$20.82M	-26.3%
Mar 2002	-$16.49M	-41.4%
Dec 2001	-$11.66M	+10.4%
Sep 2001	-$13.01M	+21.6%
Jun 2001	-$16.60M	-43.1%
Mar 2001	-$11.60M	-14.6%
Dec 2000	-$10.12M	-4.2%
Sep 2000	-$9.71M	+17.1%
Jun 2000	-$11.71M	-80.3%
Mar 2000	-$6.49M	-

FAQ

What is the current quarterly EBITDA of EXEL?: As of today, EXEL quarterly EBITDA is $275.36M
What is EXEL quarterly EBITDA most recent change?: EXEL quarterly EBITDA was up +7.82% on September 1, 2026
What is 1-year change in EXEL quarterly EBITDA?: EXEL quarterly EBITDA is up +4.39% year-over-year
How far is EXEL quarterly EBITDA from its all-time high?: EXEL quarterly EBITDA is currently -2.93% below its historical high of $283.68M set on June 28, 2024
How does EXEL quarterly EBITDA rank versus sector peers?: EXEL quarterly EBITDA is higher than 92.51% of companies in Healthcare sector
When is EXEL next earnings release?: The next earnings release for EXEL is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.03B$11.58M+1.13%

September 1, 2026

Summary

Current Value: As of today, EXEL TTM EBITDA is $1.03B, up +1.13% on September 1, 2026
Historical Performance: EXEL TTM EBITDA is up +21.40% year-over-year, up +1187.69% over the past 3 years
All-Time High Comparison: EXEL TTM EBITDA is currently at its all-time high
3-Year Low Comparison: EXEL TTM EBITDA is +1187.69% above its 3-year low of $80.14M reached on an earlier date
Sector Comparison: EXEL TTM EBITDA is higher than 92.80% of companies in Healthcare sector

Performance

EXEL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 1, 26	$1.03B	+1.1%	+21.4%	+1187.7%	+383.1%
Annual EBITDA	Dec 1, 25	$921.76M	–	+28.2%	+314.5%	+643.2%
Quarterly EBITDA	Sep 1, 26	$275.36M	+7.8%	+4.4%	+2539.6%	+376.5%
Price	Nov 5, 26	$68.71	+21.2%	+70.2%	+227.2%	+254.9%
PE Ratio	Nov 5, 26	20.56	+15.4%	+20.9%	-72.5%	-45.8%
TTM Revenue	Sep 1, 26	$2.50B	+2.5%	+9.1%	+40.7%	+99.1%
TTM EPS	Sep 1, 26	$3.34	+5.0%	+40.7%	+1090.5%	+555.2%
	Sep 1, 26	$1.00B	+1.2%	+22.4%	+2347.9%	+416.7%
TTM Net Income	Sep 1, 26	$885.14M	+2.9%	+30.6%	+861.3%	+438.8%

TTM EBITDA Highs

EXEL TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.03B	Sep 1, 26	at high
3Y	$1.03B	Sep 1, 26	at high
5Y	$1.03B	Sep 1, 26	at high
All	$1.03B	Sep 1, 26	at high

TTM EBITDA Lows

EXEL TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$850.00M	N/A	+21.4%
3Y	$80.14M	N/A	+1187.7%
5Y	$80.14M	Sep 29, 23	+1187.7%
All	-$238.61M	Jun 30, 14	+532.5%

TTM EBITDA History

Month	Value	Change
Sep 2026	$1.03B	+1.1%
Jun 2026	$1.02B	+3.5%
Mar 2026	$985.84M	+7.0%
Dec 2025	$921.76M	+8.4%
Sep 2025	$850.00M	+8.8%
Jun 2025	$781.52M	-7.4%
Mar 2025	$844.28M	+17.5%
Dec 2024	$718.75M	+13.0%
Sep 2024	$635.96M	+48.1%
Jun 2024	$429.38M	+81.3%
Mar 2024	$236.84M	+12.5%
Dec 2023	$210.58M	+162.8%
Sep 2023	$80.14M	-56.7%
Jun 2023	$185.19M	-1.3%
Mar 2023	$187.59M	-19.9%
Dec 2022	$234.29M	-40.7%
Sep 2022	$395.00M	+10.0%
Jun 2022	$359.02M	-8.8%
Mar 2022	$393.53M	+29.3%
Dec 2021	$304.25M	+42.4%
Sep 2021	$213.60M	+82.9%
Jun 2021	$116.81M	+72.5%
Mar 2021	$67.71M	-45.4%
Dec 2020	$124.03M	-29.4%
Sep 2020	$175.68M	-47.1%
Jun 2020	$332.37M	-4.3%
Mar 2020	$347.46M	-8.0%
Dec 2019	$377.82M	-8.3%
Sep 2019	$411.88M	-2.2%
Jun 2019	$421.06M	+1.8%
Mar 2019	$413.61M	-6.5%
Dec 2018	$442.43M	+20.7%
Sep 2018	$366.40M	+13.8%
Jun 2018	$321.98M	+22.2%
Mar 2018	$263.52M	+55.7%
Dec 2017	$169.30M	-3.1%
Sep 2017	$174.75M	+70.5%
Jun 2017	$102.52M	+85.9%
Mar 2017	$55.15M	+836.8%
Dec 2016	-$7.49M	+90.9%
Sep 2016	-$81.92M	+35.6%
Jun 2016	-$127.25M	+7.5%
Mar 2016	-$137.60M	-15.7%
Dec 2015	-$118.97M	+9.2%
Sep 2015	-$130.99M	+7.6%
Jun 2015	-$141.76M	+18.0%
Mar 2015	-$172.92M	+19.4%
Dec 2014	-$214.47M	+6.5%
Sep 2014	-$229.48M	+3.8%
Jun 2014	-$238.61M	-4.8%
Mar 2014	-$227.75M	-16.0%
Dec 2013	-$196.35M	-14.9%
Sep 2013	-$170.83M	-22.8%
Jun 2013	-$139.09M	-15.2%

Month	Value	Change
Mar 2013	-$120.75M	-10.8%
Dec 2012	-$108.96M	-479.9%
Sep 2012	-$18.79M	-121.3%
Jun 2012	$88.23M	-13.7%
Mar 2012	$102.27M	-4.0%
Dec 2011	$106.49M	+140.6%
Sep 2011	$44.26M	+216.9%
Jun 2011	-$37.87M	-12.2%
Mar 2011	-$33.76M	+25.0%
Dec 2010	-$45.04M	+33.2%
Sep 2010	-$67.38M	+15.2%
Jun 2010	-$79.46M	+20.0%
Mar 2010	-$99.27M	+3.3%
Dec 2009	-$102.65M	+5.3%
Sep 2009	-$108.39M	+22.2%
Jun 2009	-$139.26M	+8.0%
Mar 2009	-$151.43M	+7.2%
Dec 2008	-$163.20M	+3.9%
Sep 2008	-$169.80M	-1.0%
Jun 2008	-$168.19M	-6.0%
Mar 2008	-$158.64M	-8.9%
Dec 2007	-$145.72M	-7.0%
Sep 2007	-$136.23M	-9.9%
Jun 2007	-$123.96M	-8.8%
Mar 2007	-$113.90M	-3.7%
Dec 2006	-$109.84M	-5.6%
Sep 2006	-$104.01M	-3.3%
Jun 2006	-$100.69M	-25.6%
Mar 2006	-$80.20M	-5.2%
Dec 2005	-$76.24M	-5.0%
Sep 2005	-$72.60M	-2.3%
Jun 2005	-$70.97M	+19.5%
Mar 2005	-$88.14M	+1.0%
Dec 2004	-$89.06M	-2.9%
Sep 2004	-$86.52M	-2.6%
Jun 2004	-$84.36M	-2.9%
Mar 2004	-$82.01M	-5.5%
Dec 2003	-$77.76M	-4.3%
Sep 2003	-$74.54M	-6.5%
Jun 2003	-$70.01M	+1.0%
Mar 2003	-$70.73M	-4.0%
Dec 2002	-$68.04M	-5.0%
Sep 2002	-$64.78M	-4.5%
Jun 2002	-$61.98M	-7.3%
Mar 2002	-$57.76M	-9.3%
Dec 2001	-$52.87M	-3.0%
Sep 2001	-$51.33M	-6.9%
Jun 2001	-$48.03M	-11.3%
Mar 2001	-$43.13M	-13.4%
Dec 2000	-$38.03M	-36.3%
Sep 2000	-$27.91M	-53.4%
Jun 2000	-$18.20M	-180.3%
Mar 2000	-$6.49M	-

FAQ

What is the current TTM EBITDA of EXEL?: As of today, EXEL TTM EBITDA is $1.03B
What is EXEL TTM EBITDA most recent change?: EXEL TTM EBITDA was up +1.13% on September 1, 2026
What is 1-year change in EXEL TTM EBITDA?: EXEL TTM EBITDA is up +21.40% year-over-year
How far is EXEL TTM EBITDA from its all-time high?: EXEL TTM EBITDA is currently at its all-time high
How does EXEL TTM EBITDA rank versus sector peers?: EXEL TTM EBITDA is higher than 92.80% of companies in Healthcare sector
When is EXEL next earnings release?: The next earnings release for EXEL is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

EXEL Official Website www.exelixis.com
EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel